# Juniperus communis (Juniper)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/juniperus-communis
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 2 / 10
**Category:** European
**Also Known As:** Common Juniper, Juniper Berry, European Juniper, Gin Berry, Genévrier, Wacholderbeere, Enebro, Ginepro, Juniperus, Ground Juniper

## Overview

Juniperus communis is a coniferous shrub whose berries contain bioactive monoterpenes, primarily alpha-pinene and terpinen-4-ol, along with flavonoids such as quercetin and rutin. These compounds exert their effects primarily through inhibition of NF-κB signaling and modulation of [pro-inflammatory cytokine](/ingredients/condition/inflammation) cascades, supporting digestive and anti-inflammatory applications.

## Health Benefits

• May improve functional dyspepsia symptoms - supported by one human RCT showing statistically significant improvements with Roleca® Juniper 100mg daily
• Reduces [inflammatory](/ingredients/condition/inflammation) markers - preclinical evidence shows dose-dependent reductions in IL-1β, IL-18, and NF-κB in rat models
• Demonstrates [antioxidant activity](/ingredients/condition/antioxidant) - animal studies show restoration of total antioxidant capacity and reduction in oxidative stress markers (MDA, NO)
• Provides analgesic effects - rodent pain models showed dose-dependent pain relief comparable to aspirin
• May enhance chemotherapy sensitivity - in vitro studies show potentiation of 5-fluorouracil and gemcitabine in cancer cells

## Mechanism of Action

The primary bioactive monoterpenes in Juniperus communis, particularly terpinen-4-ol and alpha-pinene, inhibit the NF-κB transcription factor pathway, thereby suppressing downstream production of [pro-inflammatory cytokine](/ingredients/condition/inflammation)s including IL-1β and IL-18. Flavonoid constituents such as quercetin additionally inhibit cyclooxygenase (COX) and lipoxygenase (LOX) enzymes, reducing prostaglandin and leukotriene synthesis at the cellular level. These combined mechanisms contribute to the carminative and mild diuretic effects recognized in the ESCOP monograph, likely mediated through smooth [muscle relaxation](/ingredients/condition/sleep) in the gastrointestinal tract.

## Clinical Summary

The most notable human clinical evidence involves a randomized controlled trial using Roleca® standardized juniper extract at 100mg daily, which demonstrated statistically significant improvements in functional dyspepsia symptoms compared to placebo. Preclinical rat model studies have shown dose-dependent reductions in IL-1β, IL-18, and NF-κB inflammatory markers, providing mechanistic support for traditional [anti-inflammatory](/ingredients/condition/inflammation) use. The overall human clinical evidence base remains limited in scope, with few large-scale RCTs published, making the dyspepsia RCT the primary controlled human data point currently available. ESCOP monograph recognition reflects a broader consensus built on traditional use, pharmacological data, and the available clinical evidence combined.

## Nutritional Profile

Juniperus communis berries contain a complex array of bioactive compounds. Essential oils constitute 0.2–3.4% of dry weight, dominated by α-pinene (up to 50–80% of volatile fraction), β-pinene, sabinene, myrcene, limonene, and terpinen-4-ol. Flavonoids are present at approximately 0.5–1.2% dry weight, including amentoflavone, quercetin, rutin, isoscutellarein, and apigenin glycosides. Diterpene acids (communic acid, isocommunic acid, totarol) occur at trace to low concentrations (~0.1–0.5% dry weight). Proanthocyanidins and condensed tannins contribute approximately 1–3% dry weight. Sugars (primarily glucose, fructose) comprise roughly 10–33% of berry dry weight depending on ripeness. Organic acids including malic, acetic, and formic acids are present at ~1–5% dry weight. Resin constituents including juniperol and juniperic acid (a 16-hydroxy palmitic acid derivative) are found in the waxy cuticle. Micronutrients include moderate vitamin C (~10–30 mg/100g fresh weight), small amounts of B-vitamins (thiamine, riboflavin), potassium (~200 mg/100g dry weight), calcium (~80–100 mg/100g dry weight), magnesium (~30–50 mg/100g dry weight), and trace iron and zinc. Dietary fiber is substantial at approximately 15–20% dry weight. Bioavailability of essential oil monoterpenes is high due to lipophilicity and rapid GI absorption; flavonoid bioavailability is moderate and enhanced by co-consumption with fats; polyphenols undergo significant phase II conjugation post-absorption. Standardized extracts such as Roleca® are typically normalized to volatile oil content to ensure consistency.

## Dosage & Preparation

The only clinically studied dosage is 100mg daily of Roleca® Juniper for functional dyspepsia. Preclinical studies used ethanolic needle extracts at 25-100% concentrations (equivalent to ~200mg/kg body weight in rats), but human equivalents are not established. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Juniperus communis is generally well-tolerated at typical supplemental doses, but prolonged high-dose use may cause renal irritation due to the stimulating effect of terpinen-4-ol on renal tubular epithelium, and it is contraindicated in individuals with existing kidney disease or [inflammatory](/ingredients/condition/inflammation) kidney conditions. It is firmly contraindicated during pregnancy, as the volatile oil components may stimulate uterine contractions and carry a risk of abortifacient effects at higher doses. Potential drug interactions include additive effects with diuretic medications, which could increase the risk of electrolyte imbalance, and possible interference with lithium excretion due to its diuretic properties. Individuals taking antidiabetic medications should use caution, as preclinical data suggest some hypoglycemic activity that could potentiate drug effects.

## Scientific Research

Clinical evidence is limited to one RCT evaluating Roleca® Juniper (100mg daily) for functional dyspepsia, showing significant symptom improvement versus placebo. Most evidence comes from preclinical studies including rat inflammation models demonstrating [anti-inflammatory](/ingredients/condition/inflammation) effects at 25-100% ethanolic extract concentrations and in vitro cancer cell studies showing p53 activation and PI3K/Akt inhibition.

## Historical & Cultural Context

In traditional European medicine, Juniperus communis has been used for centuries to manage [inflammatory](/ingredients/condition/inflammation) disorders, abdominal issues, and pain. Berries and needles were traditionally applied for digestive complaints, urinary tract infections, and rheumatism in ethnobotanical practices across Europe.

## Synergistic Combinations

Ginger, Peppermint, Turmeric, Milk Thistle, Licorice Root

## Frequently Asked Questions

### What is the clinically studied dose of juniper berry for digestive health?

The human RCT supporting juniper's use for functional dyspepsia used a standardized extract called Roleca® at 100mg daily. This specific preparation is distinct from raw juniper berry powder, and results from this trial may not be directly extrapolated to other non-standardized supplement products on the market.

### What are the main active compounds in Juniperus communis berries?

The primary bioactive constituents of Juniperus communis berries include monoterpene volatile oils, most notably alpha-pinene, myrcene, and terpinen-4-ol, which are responsible for the carminative and diuretic effects. Polyphenolic flavonoids including quercetin, rutin, and amentoflavone also contribute to anti-inflammatory and antioxidant activity.

### Can you take juniper berry supplements if you have kidney problems?

No, juniper berry supplements are contraindicated in individuals with kidney disease, nephritis, or any inflammatory condition of the urinary tract. The terpinen-4-ol content exerts a direct stimulating effect on renal tubular tissue, which can aggravate existing kidney pathology and is a specific caution noted in ESCOP guidelines.

### Is juniper berry safe to take during pregnancy?

Juniper berry supplements are contraindicated during pregnancy due to the uterotonic properties of its volatile oil constituents, particularly terpinen-4-ol, which can stimulate uterine smooth muscle contractions. This contraindication is formally recognized in the ESCOP monograph, and the herb should be avoided throughout all trimesters of pregnancy.

### How does juniper berry reduce inflammation at the molecular level?

Juniper berry compounds suppress inflammation primarily by inhibiting NF-κB, a master transcription factor that regulates the expression of pro-inflammatory genes encoding cytokines such as IL-1β and IL-18. Rat model studies have demonstrated these reductions in a dose-dependent manner, while flavonoids like quercetin simultaneously inhibit COX and LOX enzymes to reduce prostaglandin synthesis.

### What is the most bioavailable form of juniper berry supplement?

Standardized extracts like Roleca® Juniper demonstrate superior bioavailability compared to whole berry powders, as evidenced by clinical efficacy at 100mg daily doses in dyspepsia studies. The standardization process concentrates volatile oils and phenolic compounds, improving absorption and consistency of active constituents. Liquid extracts and encapsulated standardized formulations typically show better gastrointestinal uptake than dried whole berries.

### Does juniper berry interact with common blood pressure or diuretic medications?

Juniper berry may potentiate diuretic effects and should be used cautiously with thiazide diuretics, loop diuretics, or ACE inhibitors due to its mild diuretic properties and potential effects on renal function. Concurrent use with antihypertensive medications requires medical supervision, as juniper may enhance blood pressure-lowering effects. Patients on chronic kidney medications should consult healthcare providers before supplementation.

### What does current clinical research show about juniper berry's effectiveness compared to standard dyspepsia treatments?

The single human RCT showing significant improvements in functional dyspepsia with Roleca® Juniper 100mg daily indicates promising efficacy, though head-to-head comparison studies against standard prokinetic or antacid medications are lacking. Preclinical evidence supporting anti-inflammatory and antioxidant mechanisms is robust in animal models, but larger clinical trials are needed to establish superiority over conventional treatments. Current evidence supports juniper as a potential complementary option rather than a first-line replacement for conventional dyspepsia management.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*